Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten S Kramer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Beilstein Journal of Organic Chemistry|August 16, 2013
Thiourea-catalyzed Diels-Alder reaction of a naphthoquinone monoketal dienophileCarsten S Kramer, Stefan Bräse
Molecules (Basel, Switzerland)|May 28, 2022
Immuno-Imaging (PET/SPECT)-Quo Vadis?Carsten S Kramer, Antonia Dimitrakopoulou-Strauss
Frontiers in Medicine|October 24, 2024
Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer-A case reportCarsten S Kramer, Jingjing Zhang, Richard P Baum
Beilstein Journal of Organic Chemistry|November 16, 2019
A new approach to silicon rhodamines by Suzuki-Miyaura coupling - scope and limitationsThines Kanagasundaram, Antje Timmermann, Carsten S Kramer, et al.
Beilstein Journal of Organic Chemistry|November 1, 2019
Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangementJessica Matthias, Thines Kanagasundaram, Klaus Kopka, et al.
Dalton Transactions (Cambridge, England : 2003)|May 15, 2020
Rhenium and technetium-complexed silicon rhodamines as near-infrared imaging probes for bimodal SPECT- and optical imagingThines Kanagasundaram, Carsten S Kramer, Eszter Boros, et al.
Cancers|June 13, 2025
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand TherapyCarsten S Kramer, Aleksandr Eismant, Aditi Mishra, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPiLukas Greifenstein, Carsten S Kramer, Euy Sung Moon, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3Lukas Greifenstein, Marcel Martin, Sarah Stephan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Beilstein Journal of Organic Chemistry|August 16, 2013
Thiourea-catalyzed Diels-Alder reaction of a naphthoquinone monoketal dienophileCarsten S Kramer, Stefan Bräse
Molecules (Basel, Switzerland)|May 28, 2022
Immuno-Imaging (PET/SPECT)-Quo Vadis?Carsten S Kramer, Antonia Dimitrakopoulou-Strauss
Frontiers in Medicine|October 24, 2024
Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer-A case reportCarsten S Kramer, Jingjing Zhang, Richard P Baum
Beilstein Journal of Organic Chemistry|November 16, 2019
A new approach to silicon rhodamines by Suzuki-Miyaura coupling - scope and limitationsThines Kanagasundaram, Antje Timmermann, Carsten S Kramer, et al.
Beilstein Journal of Organic Chemistry|November 1, 2019
Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangementJessica Matthias, Thines Kanagasundaram, Klaus Kopka, et al.
Dalton Transactions (Cambridge, England : 2003)|May 15, 2020
Rhenium and technetium-complexed silicon rhodamines as near-infrared imaging probes for bimodal SPECT- and optical imagingThines Kanagasundaram, Carsten S Kramer, Eszter Boros, et al.
Cancers|June 13, 2025
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand TherapyCarsten S Kramer, Aleksandr Eismant, Aditi Mishra, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPiLukas Greifenstein, Carsten S Kramer, Euy Sung Moon, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3Lukas Greifenstein, Marcel Martin, Sarah Stephan, et al.
Pageof 1